Literature DB >> 21544855

Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management.

Erfan Nur1, Bart J Biemond, Hans-Martin Otten, Dees P Brandjes, John-John B Schnog.   

Abstract

Sickle cell disease (SCD) is a hemoglobinopathy characterized by hemolytic anemia, increased susceptibility to infections and vaso-occlusion leading to a reduced quality of life and life expectancy. Oxidative stress is an important feature of SCD and plays a significant role in the pathophysiology of hemolysis, vaso-occlusion and ensuing organ damage in sickle cell patients. Reactive oxygen species (ROS) and the (end-)products of their oxidative reactions are potential markers of disease severity and could be targets for antioxidant therapies. This review will summarize the role of ROS in SCD and their potential implication for SCD management.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21544855     DOI: 10.1002/ajh.22012

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  64 in total

Review 1.  Spectrin's chimeric E2/E3 enzymatic activity.

Authors:  Steven R Goodman; Rachel Petrofes Chapa; Warren E Zimmer
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

2.  Targeting Mac-1-mediated leukocyte-RBC interactions uncouples the benefits for acute vaso-occlusion and chronic organ damage.

Authors:  Grace Chen; Jungshan Chang; Dachuan Zhang; Sandra Pinho; Jung-Eun Jang; Paul S Frenette
Journal:  Exp Hematol       Date:  2016-07-05       Impact factor: 3.084

3.  NRF2 mediates γ-globin gene regulation through epigenetic modifications in a β-YAC transgenic mouse model.

Authors:  Xingguo Zhu; Caixia Xi; Alexander Ward; Mayuko Takezaki; Huidong Shi; Kenneth R Peterson; Betty S Pace
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-26

4.  Vascular TSP1-CD47 signaling promotes sickle cell-associated arterial vasculopathy and pulmonary hypertension in mice.

Authors:  Enrico M Novelli; Lynda Little-Ihrig; Heather E Knupp; Natasha M Rogers; Mingyi Yao; Jeffrey J Baust; Daniel Meijles; Claudette M St Croix; Mark A Ross; Patrick J Pagano; Evan R DeVallance; George Miles; Karin P Potoka; Jeffrey S Isenberg; Mark T Gladwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-03-20       Impact factor: 5.464

5.  Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease.

Authors:  Grace Chen; Dachuan Zhang; Tobias A Fuchs; Deepa Manwani; Denisa D Wagner; Paul S Frenette
Journal:  Blood       Date:  2014-03-11       Impact factor: 22.113

Review 6.  Potential role of LSD1 inhibitors in the treatment of sickle cell disease: a review of preclinical animal model data.

Authors:  Angela Rivers; Ramasamy Jagadeeswaran; Donald Lavelle
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-08-01       Impact factor: 3.619

7.  Inheritance of the Bantu/Benin haplotype causes less severe hemolytic and oxidative stress in sickle cell anemia patients treated with hydroxycarbamide.

Authors:  Jéssika V Okumura; Danilo G H Silva; Lidiane S Torres; Edis Belini-Junior; Willian M Barberino; Renan G Oliveira; Gisele C S Carrocini; Gabriela B Gelaleti; Clarisse L C Lobo; Claudia R Bonini-Domingos
Journal:  J Hum Genet       Date:  2016-03-10       Impact factor: 3.172

Review 8.  L-glutamine for sickle cell disease: Knight or pawn?

Authors:  Alina Sadaf; Charles T Quinn
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-27

9.  Efficient Quantitative Analysis of Carboxyalkylpyrrole Ethanolamine Phospholipids: Elevated Levels in Sickle Cell Disease Blood.

Authors:  Junhong Guo; Hua Wang; Borys Hrinczenko; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2016-06-24       Impact factor: 3.739

10.  Erythrocyte NADPH oxidase activity modulated by Rac GTPases, PKC, and plasma cytokines contributes to oxidative stress in sickle cell disease.

Authors:  Alex George; Suvarnamala Pushkaran; Diamantis G Konstantinidis; Sebastian Koochaki; Punam Malik; Narla Mohandas; Yi Zheng; Clinton H Joiner; Theodosia A Kalfa
Journal:  Blood       Date:  2013-01-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.